What must pharmaceutical firms do to exploit the opportunities and counter the threats?

Pharmaceutical firms must invest in research and development to innovate and create new therapies that address unmet medical needs, thereby exploiting market opportunities. They should also adopt agile supply chain strategies to mitigate risks and ensure timely delivery of products. Additionally, engaging in strategic partnerships and collaborations can enhance their capabilities and expand market reach. Lastly, firms need to prioritize regulatory compliance and adapt to changing healthcare policies to counter potential threats.